Some CEOs are asking when they'll make money from AI, BCG's Sylvain Duranton told Business Insider. He said the biggest factor in succeeding with AI isn't the tech, but changing how people work.

Welcome to the Relmada Therapeutics first-quarter 2025 earnings call. (Operator Instructions) As a reminder, this conference is being recorded, and will be available for replay on the location website ...

We caution listeners that during this call, Relmada’s management team will be making forward-looking statements ... NDV-01 forms a spherical soft matrix within the bladder that sequesters ...

The bacillus Calmette–Guérin (BCG) vaccine, initially developed to provide protection against TB, also protects against leprosy; and the magnitude of this effect varies. Previous meta-analyses ...

Two days of muscle-strengthening exercises per week is also recommended. Some ways to get this exercise include: If you have high blood pressure and check your own blood pressure regularly, make sure ...

Q1 2025 Earnings Call Transcript May 12, 2025 Relmada Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0 ...

The company says the lab helps it make improvements for workers at its assembly line stations as well as cut costs. The reporter moved the rear door of the Jeep Wrangler and looked for the pins to ...

Discover comprehensive analysis and 1,400+ detailed Pro Research Reports available on InvestingPro, helping investors make informed decisions ... intermediate-risk and BCG-naive markets.